Patents by Inventor Petr Cherepanov

Petr Cherepanov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140128316
    Abstract: The present invention provides nucleic acid molecules which include a region specifically interacting with the nucleic acid encoding the LEDGF/P75 protein or the nucleic acid encoding a fragment of a LEDGF/P75 protein and methods and uses of such nucleic acid molecules.
    Type: Application
    Filed: September 18, 2013
    Publication date: May 8, 2014
    Inventors: Zeger DEBYSER, Petr Cherepanov, Erik De Clercq
  • Publication number: 20120028889
    Abstract: The present invention provides nucleic acid molecules which include a region specifically interacting with the nucleic acid encoding the LEDGF/P75 protein or the nucleic acid encoding a fragment of a LEDGF/P75 protein and methods and uses of such nucleic acid molecules.
    Type: Application
    Filed: June 24, 2011
    Publication date: February 2, 2012
    Applicant: K.U. Leuven Research & Development
    Inventors: Zeger DEBYSER, Petr Cherepanov, Erik De Clercq
  • Patent number: 8008470
    Abstract: The present invention provides nucleic acid molecules which include a region specifically interacting with the nucleic acid encoding the LEDGF/P75 protein or the nucleic acid encoding a fragment of a LEDGF/P75 protein and methods and uses of such nucleic acid molecules.
    Type: Grant
    Filed: February 25, 2009
    Date of Patent: August 30, 2011
    Assignee: K.U. Leuven Research & Development
    Inventors: Zeger Debyser, Petr Cherepanov, Erik De Clercq
  • Publication number: 20090247610
    Abstract: The present invention provides nucleic acid molecules which include a region specifically interacting with the nucleic acid encoding the LEDGF/P75 protein or the nucleic acid encoding a fragment of a LEDGF/P75 protein and methods and uses of such nucleic acid molecules.
    Type: Application
    Filed: February 25, 2009
    Publication date: October 1, 2009
    Inventors: Zeger DEBYSER, Petr Cherepanov, Erik De Clercq
  • Patent number: 7514233
    Abstract: The present invention provides integrase interacting proteins including cofactors which promote strand transfer activity of viral integrase, more particularly HIV integrase, and methods and uses relating thereto. The present invention also relates to methods of identifying molecules interacting with integrase interacting protein and their use as an antiviral.
    Type: Grant
    Filed: September 26, 2003
    Date of Patent: April 7, 2009
    Assignee: K.U. Leuven Research & Development
    Inventors: Zeger Debyser, Petr Cherepanov, Erik De Clercq
  • Publication number: 20070259358
    Abstract: In a study of HIV-1 integrase (IN) complexes derived from nuclei of human cells stably expressing the viral protein from a synthetic gene it was demonstrated that in the nuclear extracts IN exists as part of a large distinct complex with apparent Stokes radius of 61 ?, which dissociates upon dilution yielding a core molecule of 41 ?. The IN complexes were isolated from cells expressing FLAG-tagged IN. By present invention it was demonstrated that the 41 ? core is tetramer of IN, whereas 61 ? molecules are composed of IN tetramers associated with a cellular protein with an apparent molecular weight of 76 kDa. This integrase interacting protein (Inip76) was found to be identical to LEDGF/DFS70/p75 a protein implicated in regulation of gene expression and cellular stress-response. HIV-1 IN and Inip76 co-localized in the nuclei of human cells stably expressing IN. Furthermore, it has been demonstrated by present invention that recombinant Inip76 strongly promoted strand-transfer activity of HIV-1 IN in vitro.
    Type: Application
    Filed: February 15, 2007
    Publication date: November 8, 2007
    Inventors: Zeger DEBYSER, Petr CHEREPANOV, Erik DE CLERCQ
  • Publication number: 20060275748
    Abstract: In a study of HIV-1 integrase (IN) complexes derived from nuclei of human cells stably expressing the viral protein from a synthetic gene it was demonstrated that in the nuclear extracts IN exists as part of a large distinct complex with apparent Stokes radius of 61 ?, which dissociates upon dilution yielding a core molecule of 41 ?. The IN complexes were isolated from cells expressing FLAG-tagged IN. By present invention it was demonstrated that the 41 ? core is tetramer of IN, whereas 61 ? molecules are composed of IN tetramers associated with a cellular protein with an apparent molecular weight of 76 kDa. This integrase interacting protein (Inip76) was found to be identical to LEDGF/DFS70/p75 a protein implicated in regulation of gene expression and cellular stress-response. HIV-1 IN and Inip76 co-localized in the nuclei of human cells stably expressing IN. Furthermore, it has been demonstrated by present invention that recombinant Inip76 strongly promoted strand-transfer activity of HIV-1 IN in vitro.
    Type: Application
    Filed: September 26, 2003
    Publication date: December 7, 2006
    Applicant: KULEUVEN RESEARCH AND DEVELOPMENT
    Inventors: Zeger Debyser, Petr Cherepanov, Erik De Clercq